Particle.news

Download on the App Store

Stanford Blood Test Tracks Organ Aging to Predict Alzheimer’s and Mortality

AI-driven proteomics in 45,000 UK Biobank samples highlights extreme brain aging as the key marker for mortality risk in addition to Alzheimer’s disease

Image
New research from Stanford scientists found that an “extremely aged” brain was associated not only with an increased risk of developing Alzheimer’s disease, but a 182% increased risk of dying in the next 15 years.
Image
Image

Overview

  • The blood test quantifies biological ages of 11 organ systems by measuring about 3,000 protein biomarkers and applying machine learning to samples from 45,000 UK Biobank participants.
  • Organs appearing older than their chronological age are linked to higher disease risk in the corresponding system, with aged brains tied to a threefold increase in Alzheimer’s risk compared to average brain age.
  • Participants with extremely aged brains faced a 182% higher risk of dying within 15 years while those with exceptionally youthful brains had a 40% lower mortality risk.
  • Stanford researchers say the test costs approximately $1,000 for research use and aim to bring a commercial version to market within two to three years through university–startup partnerships.
  • Plans are underway for double-blind trials to evaluate whether lifestyle changes such as exercise and smoking cessation can directly reverse organ-specific biological aging.